Sort   by:  
 Page size 
UnknownAn antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes.
Not available
S-EPMC10954819 | biostudies-literature
UnknownPrognostic value of PDL1 expression in pancreatic cancer.
Not available
S-EPMC5342072 | biostudies-literature
UnknownA randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452.
Not available
S-EPMC9946892 | biostudies-literature
UnknownAnti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?
Not available
S-EPMC5522327 | biostudies-literature
UnknownDevelopment of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.
Not available
S-EPMC8491978 | biostudies-literature
UnknownPhase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.
Not available
S-EPMC8802018 | biostudies-literature
UnknownImmunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine.
Not available
S-EPMC10881471 | biostudies-literature
UnknownMolecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic study.
Not available
S-EPMC4037827 | biostudies-literature
UnknownDistinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes.
Not available
S-EPMC5958058 | biostudies-literature
UnknownEvidence-based clinical guidelines for immigrants and refugees.
Not available
S-EPMC3168666 | biostudies-literature
Sort   by:  
 Page size